FIRE, A Collective Journey for Re-envisioning Community Health in Pakistan

Ferozsons Initiative for Research Excellence (FIRE) aims to re-envision Pakistan's public health landscape by providing cutting edge training in clinical research. The overarching goal of FIRE is to seed and develop a culture of high-quality research in clinical and population health sciences in Pakistan as well as the broader region. Towards achieving this goal, the FIRE team has defined the following objectives:


Support collaborative research between clinicians and basic scientists to reduce mortality and promote healthy lives.


Use cutting-edge scientific methods generate, and apply new knowledge to developing sustainable solutions to public health problems in Pakistan.

The program

Pakistan is home to several communicable and non-communicable diseases.  Further complicating the current situation is the double burden of communicable and non-communicable diseases such as TB and diabetes or pneumonia and diabetes. Designing preventive interventions for such conditions require (i) an in-depth understanding of the disease determinants and (ii) a system to translate this knowledge into designing targeted interventions for lowering the overall burden of disease. Guided by the principals of integrity, innovation and team-work, the program aims to change the landscape of community health in Pakistan. The overarching goals of the program is to develop high quality and locally relevant translational research program for understanding and addressing the rapidly evolving healthcare needs of the local community. 

Program goals

Impact measurements

Impact measurement is essential for self-evaluation and self-improvement.  Such measurement should ideally be objective, measurable, and meaningful.  To that effect, the center will put in a place a robust mechanism to measure the impact.  The measurement will include indicators and metrics of scientific output success, its investigators’ reputation and standing, and the success of its trainees and partner programs.  These include, but will not be limited to, the number of high-impact publications, work output that leads to practice change, research funding and revenues, number of ongoing clinical trials, patents awarded, h-index of investigators, and the number of investigators in the peer-reviewed ”Stanford List” of World’s top 2% most influential scientists.